Profile
Kevin Sun is currently the Chief Financial Officer, Secretary & Treasurer at DermTech, Inc. He previously worked as the Senior Manager-Financial Planning & Analysis at Alere San Diego, Inc. from 2004 to 2008.
From 2008 to 2018, he was the Vice President-Treasury & Controller at DexCom, Inc. He also held the position of Vice President-Finance at DermTech Operations, Inc. Additionally, he worked as the Senior Manager-Financial Planning & Analysis at Biosite, Inc. (Massachusetts) from 2004 to 2008.
Mr. Sun completed his undergraduate and graduate degrees at Kelley School of Business and holds an MBA.
Kevin Sun active positions
| Companies | Position | Start |
|---|---|---|
| DERMTECH | Director of Finance/CFO | 2019-09-11 |
Former positions of Kevin Sun
| Companies | Position | End |
|---|---|---|
| DEXCOM, INC. | Director of Finance/CFO | 2017-08-31 |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic instruments | Corporate Officer/Principal | 2008-05-31 |
Biosite, Inc. (Massachusetts)
Biosite, Inc. (Massachusetts) Part of Abbott Laboratories, Biosite, Inc. is a consulting firm founded by Kenneth F. Buechler. The company, based in MA, specializes in strategic alliances, business development, and M&A advisory services within the biopharmaceutical field. The company has extensive expertise in therapeutic antibodies & proteins, oncology, autoimmune & infectious diseases, diagnostics, and specialty pharmaceuticals. Biosite, Inc. has been retained by various clients, including MedinCell S.A., Medin Cell Corp., Inc. & Undisclosed Mexican generics company, Avid Bioservices, Chiome Bioscience, Pfizer Animal Health, CombiChem, Kaken Pharmaceutical Co., Ltd., MediLite Diagnostics, Molecular Research Institute (Mri), and Structural Bioinformatics Inc. | Corporate Officer/Principal | 2007-12-31 |
DermTech Operations, Inc.
DermTech Operations, Inc. Medical SpecialtiesHealth Technology Develops and markets molecular biology techniques for the analysis of various skin disorders | Director of Finance/CFO | - |
Training of Kevin Sun
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic instruments | Health Technology |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
DermTech Operations, Inc.
DermTech Operations, Inc. Medical SpecialtiesHealth Technology Develops and markets molecular biology techniques for the analysis of various skin disorders | Health Technology |
Biosite, Inc. (Massachusetts)
Biosite, Inc. (Massachusetts) Part of Abbott Laboratories, Biosite, Inc. is a consulting firm founded by Kenneth F. Buechler. The company, based in MA, specializes in strategic alliances, business development, and M&A advisory services within the biopharmaceutical field. The company has extensive expertise in therapeutic antibodies & proteins, oncology, autoimmune & infectious diseases, diagnostics, and specialty pharmaceuticals. Biosite, Inc. has been retained by various clients, including MedinCell S.A., Medin Cell Corp., Inc. & Undisclosed Mexican generics company, Avid Bioservices, Chiome Bioscience, Pfizer Animal Health, CombiChem, Kaken Pharmaceutical Co., Ltd., MediLite Diagnostics, Molecular Research Institute (Mri), and Structural Bioinformatics Inc. | |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DermTech, Inc.
DermTech, Inc. Medical SpecialtiesHealth Technology Provides non-invasive genomic testing services for skincare | Health Technology |
- Stock Market
- Insiders
- Kevin Sun
















